Jefferies Maintains Buy on Exact Sciences, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Brandon Couillard maintains a 'Buy' rating on Exact Sciences (NASDAQ:EXAS) and raises the price target from $100 to $110.
August 04, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst maintains a 'Buy' rating on Exact Sciences and raises the price target from $100 to $110.
The raised price target by Jefferies indicates a positive outlook for Exact Sciences. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100